Syncope, commonly known as fainting, is a prevalent clinical problem that healthcare professionals encounter. It is a transient loss of consciousness due to inadequate blood flow to the brain. Understanding its complexities is crucial in providing effective patient care.
Syncope results from a temporary interruption in cerebral blood flow. The key mechanisms are usually neurocardiogenic, orthostatic hypotension, or cardiac. Neurocardiogenic syncope, the most common type, involves a reflex arc that causes bradycardia or vasodilation. Orthostatic hypotension is due to a failure of compensatory mechanisms upon standing. Cardiac syncope arises from arrhythmias or structural heart diseases.
A thorough history and physical examination are essential in the evaluation of syncope. Key features to consider include precipitating events, prodromal symptoms, and post-event recovery. Special attention should be given to cardiac history as it may suggest a more serious underlying condition.
While the diagnosis of syncope is clinical, further testing may be required to identify the underlying cause. This can include electrocardiography, echocardiography, tilt table testing, or even advanced cardiac imaging. The choice of diagnostic test should be guided by the clinical suspicion.
Management of syncope is primarily targeted at preventing recurrent episodes and treating underlying causes. This can range from lifestyle modifications for orthostatic hypotension, to pharmacological therapy for reflex syncope, to device therapy for cardiac syncope.
Syncope is a complex clinical entity that requires a comprehensive approach for effective management. Understanding its pathophysiology, conducting a thorough clinical evaluation, adopting an appropriate diagnostic approach, and implementing suitable management strategies are integral steps in providing optimal patient care.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation